Animas OneTouch Ping Insulin Pump System’s Security Warning 

Animus OneTouch Ping Insulin Pump System’s Security Warning 

Animas Inc. has issued a warning regarding the cyber security of its OneTouch Ping insulin pump system. The company was notified of a cybersecurity issue with the OneTouch Ping, specifically that a person could potentially gain unauthorized access to the pump through … Read more

FDA Approves Abbott’s FreeStyle Libre Pro System


The U.S. FDA has approved the Abbott’s FreeStyle Libre Pro system, a revolutionary continuous glucose monitoring (CGM) system for healthcare professionals to use with their patients with diabetes. FreeStyle Libre Pro system is designed to empower healthcare professionals to provide better diabetes management for diabetes … Read more

IDF Launches Life for a Child (USA) Inc.

IDF - Life for a Child Logo

The International Diabetes Federation (IDF) Life for a Child Program has expanded into the U.S. to launch IDF Life for a Child (USA) Inc. (LFAC), a 501c(3) organization dedicated to saving the lives of children and youth (under 26 years … Read more

FDA Approves Medtronic MiniMed 630G

Medtronic Minimed 630G System

The U.S. FDA has approved Medtronic’s new MiniMed 630G system with SmartGuard technology. This Minimed 630G system provides better glucose control, protective action and personalized management so people with diabetes can focus less on managing diabetes and more on what matters most … Read more

FDA Approves Adlyxin, Sanofi’s New Type 2 Diabetes Drug 

Sanofi Logo

The U.S. FDA approved Sanofi’s new diabetes drug, Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels) in adults with type 2 diabetes. Adlyxin is a glucagon-like peptide-1 (GLP-1) receptor agonist, a hormone that helps normalize blood … Read more

FDA Approves t:slim Insulin Pump for Children Ages 6 and Older

From Shots to Tandem t:slim Pump

The U.S. FDA has approved Tandem Diabetes Care’s t:slim Insulin Pump for use by children age 6 and older. Until now the t:slim Insulin Pump was approved for use by children age 12 and older. This expanded pediatric indication applies to the current t:slim Pump features, with … Read more

New Medtronic Guardian Connect Mobile CGM System Approved in EU

Medtronic Guardian Connect

Medtronic has received CE (Conformité Européenne) Mark for its new Guardian Connect mobile continuous glucose monitoring (CGM) system for people with diabetes using insulin injection therapy. Guardian Connect is the first smartphone-enabled CGM system from Medtronic to receive CE Mark and … Read more

Subscribe to our Newsletter

Hide me